PROGRESSIVE SUPRANUCLEAR PALSY(PSP)

Clinical trials for PROGRESSIVE SUPRANUCLEAR PALSY(PSP) explained in plain language.

Never miss a new study

Get alerted when new PROGRESSIVE SUPRANUCLEAR PALSY(PSP) trials appear

Sign up with your email to follow new studies for PROGRESSIVE SUPRANUCLEAR PALSY(PSP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

First human test of spinal injection for rare brain disease

Disease control Completed

This study tested the safety of a new drug, NIO752, given as an injection into the spinal fluid for people with progressive supranuclear palsy (PSP), a rare and serious brain disorder. The main goal was to see if the treatment was safe and how the body processes it. About 59 part…

Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY(PSP)

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

PROGRESSIVE SUPRANUCLEAR PALSY(PSP)

Get alerted when new PROGRESSIVE SUPRANUCLEAR PALSY(PSP) trials appear

First human test of spinal injection for rare brain disease